CrowdStrike <CRWD.O>: Stephens raises target price to $280 from $260
CRWD•Related News
Xenon Pharmaceuticals Inc. <XENE.O>: Needham cuts target price to $60 from $78
XENE•
HealthEquity <HQY.O>: Barclays raises target price to $115 from $110
HQY•
EMA panel backs EU approval of Roche’s Ocrevus for pediatric relapsing MS patients 10+
RHHBY•
Merck says EU CHMP backs Keytruda-Padcev perioperative use in muscle-invasive bladder cancer
MRK•
ProCap Financial joins Russell 2000 and Russell 3000 indexes
IWM•